These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34109576)

  • 1. The role of sarcopenia in the pancreatic adenocarcinoma.
    Pessia B; Giuliani A; Romano L; Bruno F; Carlei F; Vicentini V; Schietroma M
    Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3670-3678. PubMed ID: 34109576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer.
    La Vaccara V; Cascone C; Coppola A; Farolfi T; Cammarata R; Emerenziani S; Coppola R; Caputo D
    Ann Ital Chir; 2023; 94():45-51. PubMed ID: 36810297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.
    Peng P; Hyder O; Firoozmand A; Kneuertz P; Schulick RD; Huang D; Makary M; Hirose K; Edil B; Choti MA; Herman J; Cameron JL; Wolfgang CL; Pawlik TM
    J Gastrointest Surg; 2012 Aug; 16(8):1478-86. PubMed ID: 22692586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy.
    Sui K; Okabayshi T; Iwata J; Morita S; Sumiyoshi T; Iiyama T; Shimada Y
    Surg Today; 2018 May; 48(5):545-551. PubMed ID: 29285616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer.
    Ryu Y; Shin SH; Kim JH; Jeong WK; Park DJ; Kim N; Heo JS; Choi DW; Han IW
    HPB (Oxford); 2020 Dec; 22(12):1782-1792. PubMed ID: 32354655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the sarcopenia and HALP score on postoperative outcomes in pancreatic cancer patients after pancreatoduodenectomy.
    Tazeoglu D; Benli S; Colak T; Apaydin FD
    Pancreatology; 2023 Aug; 23(5):530-536. PubMed ID: 37210304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.
    Pecorelli N; Carrara G; De Cobelli F; Cristel G; Damascelli A; Balzano G; Beretta L; Braga M
    Br J Surg; 2016 Mar; 103(4):434-42. PubMed ID: 26780231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sarcopenia as defined by EWGSOP2 on complications after pancreaticoduodenectomy and on the prognosis of pancreatic head cancer: A prospective cohort study.
    Aoki Y; Furukawa K; Suzuki D; Takayashiki T; Kuboki S; Takano S; Kawasaki Y; Shiko Y; Ohtsuka M
    Nutrition; 2022; 99-100():111660. PubMed ID: 35576875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study.
    Pecorelli N; Capretti G; Sandini M; Damascelli A; Cristel G; De Cobelli F; Gianotti L; Zerbi A; Braga M
    Ann Surg Oncol; 2018 Jan; 25(1):308-317. PubMed ID: 29116490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Yunoki K; Okabayashi H; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    PLoS One; 2024; 19(6):e0305844. PubMed ID: 38913646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative anthropomorphic radiographic measurements can predict postoperative pancreatic fistula formation following pancreatoduodenectomy.
    Box EW; Deng L; Morgan DE; Xie R; Kirklin JK; Wang TN; Heslin MJ; Reddy S; Vickers S; Dudeia V; Rose JB
    Am J Surg; 2021 Jul; 222(1):133-138. PubMed ID: 33390246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.
    Jang M; Park HW; Huh J; Lee JH; Jeong YK; Nah YW; Park J; Kim KW
    Eur Radiol; 2019 May; 29(5):2417-2425. PubMed ID: 30406311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
    Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
    Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients.
    Kymionis GD; Konstadoulakis MM; Leandros E; Manouras A; Apostolou A; Alexiou D; Katsaragakis S; Androulakis G
    J R Coll Surg Edinb; 1999 Aug; 44(4):231-5. PubMed ID: 10453145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancreaticoduodenectomy.
    Qiu G; Zhang L; Gu Z; Ren H; Du Y; Li Z; Wang C
    Med Sci Monit; 2021 Oct; 27():e931868. PubMed ID: 34599137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Tani M; Kawai M; Hirono S; Ina S; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Surg Today; 2009; 39(3):219-24. PubMed ID: 19280281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Spitz FR; Abbruzzese JL; Lee JE; Pisters PW; Lowy AM; Fenoglio CJ; Cleary KR; Janjan NA; Goswitz MS; Rich TA; Evans DB
    J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.